Advertisement

Familial atrial myopathy in a large multi-generational heart-hand syndrome pedigree carrying LMNA missense variant in rod 2B domain (p.R335W)

Published:November 19, 2021DOI:https://doi.org/10.1016/j.hrthm.2021.11.022

      Abstract

      Background

      The literature on laminopathy with ventricular phenotype is extensive. However, the pathogenicity of LMNA variations in atrial lesions still lacks research.

      Objective

      To characterize the atrial phenotype and possible mechanisms in a large Chinese family with heart-hand syndrome carrying LMNA missense variant in rod 2B domain (c.1003C>T p.R335W).

      Methods

      Clinical characteristics were collected based on the pedigree investigation. Comprehensive functional analyses, including molecular dynamic simulation, cellular, and animal functional assays, determined the pathogenicity in atrial myopathy.

      Results

      In the pedigree investigation, 6/13 of the mutation carriers showed heterogeneous cardiac phenotypes, and eight carriers also had brachydactyly. In silico molecular dynamics simulations predicted increased binding energy of R335W mutant lamin A. Atrial cardiomyocytes (HL-1, hiPSC-derived atrial cardiomyocytes) expressing R335W showed abnormal nuclear morphology, compromised DNA repair, and dysfunctional contraction. Adult zebrafish expressing mutant lamin A showed increased P wave duration in the electrocardiogram, decreased A peak velocity in echocardiography, and atrial lesions under the transmission electron microscope.

      Conclusion

      The LMNA p.R335W mutation leads to a familial heart-hand syndrome characterized by an overlapping phenotype of prominent atrial lesions and brachydactyly. The unstable lamin dimerization and impaired DNA repair are possible mechanisms underlying cardiac phenotypes. Our findings consolidated the genetic role in the course of atrial arrhythmias and cardiac aging, which is helpful to the diagnosis and treatment of cardiac laminopathy.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fatkin D.
        • MacRae C.
        • Sasaki T.
        • et al.
        Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease.
        New Engl J Medicine. 1999; 341: 1715-1724
        • Ahn J.
        • Jo I.
        • Kang S-m
        • et al.
        Structural basis for lamin assembly at the molecular level.
        Nat Commun. 2019; 10: 3757
        • Kim J.-K.
        • Louhghalam A.
        • Lee G.
        • et al.
        Nuclear lamin A/C harnesses the perinuclear apical actin cables to protect nuclear morphology.
        Nat Commun. 2018; 2017: 1-13
        • Cheedipudi S.M.
        • Matkovich S.J.
        • Coarfa C.
        • et al.
        Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.
        Circulation research. 2019; 124: 1198-1213
        • Salvarani N.
        • Crasto S.
        • Miragoli M.
        • et al.
        The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy.
        Nat Commun. 2019; 10: 2267
        • Guenantin A.C.
        • Jebeniani I.
        • Leschik J.
        • et al.
        Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy.
        J Clin Invest. 2021; : 131
        • Kumar S.
        • Baldinger S.H.
        • Gandjbakhch E.
        • et al.
        Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.
        J Am Coll Cardiol. 2016; 68: 2299-2307
        • Chauvel R.
        • Derval N.
        • Duchateau J.
        • et al.
        Persistent atrial fibrillation ablation in cardiac laminopathy: Electrophysiological findings and clinical outcomes.
        Heart Rhythm. 2021;
        • Liu H.
        • Li M.
        • Li C.
        • et al.
        Nonatrial Fibrillation Patients With Complete P Wave Disappearance.
        Stroke. 2021; 52: 1074-1078
        • Ju W.
        • Li M.
        • Wang D.W.
        • et al.
        Idiopathic isolated fibrotic atrial cardiomyopathy underlies unexplained scar-related atrial tachycardia in younger patients.
        Europace. 2018; 20: 1657-1665
        • Li C.
        • Ju W.
        • Gu K.
        • et al.
        Atrial involvement and progression of sinus node dysfunction in non-senile patients: evidences from electroanatomic mapping and long-term follow-up.
        J Interv Card Electrophysiol. 2021; 60: 365-373
        • Goette A.
        • Kalman J.M.
        • Aguinaga L.
        • et al.
        EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.
        Heart Rhythm. 2017; 14: e3-e40
        • Morival J.L.P.
        • Widyastuti H.P.
        • Nguyen C.H.H.
        • Zaragoza M.V.
        • Downing T.L.
        DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies.
        Clinical Epigenetics. 2021; 13
        • Zaragoza M.V.
        • Hakim S.A.
        • Hoang V.
        • Elliott A.M.
        Heart‐hand syndrome IV: a second family with LMNA‐related cardiomyopathy and brachydactyly.
        Clinical Genetics. 2016; 91: 499-500
        • Ye B.
        • Hou N.
        • Xiao L.
        • et al.
        Dynamic monitoring of oxidative DNA double-strand break and repair in cardiomyocytes.
        Cardiovasc Pathol. 2016; 25: 93-100
        • Zhang Y.
        • Zhu Y.
        • Lin Y.
        • et al.
        Establishment of an iPSC line (JSPHi001-A) from a patient with familial dilated cardiomyopathy and atrial fibrillation caused by LMNA missense mutation (c.1003C > T).
        Stem Cell Res. 2021; 53: 102349
        • Stallmeyer B.
        • Koopmann M.
        • Schulze-Bahr E.
        Identification of Novel Mutations in LMNAAssociated with Familial Forms of Dilated Cardiomyopathy.
        Genet Test Mol Bioma. 2012; 16: 543-549
        • Lambert J.C.
        • Baudart P.
        • De Sandre-Giovannoli A.
        • Molin A.
        • Marcelli C.
        Lamin A/C gene (LMNA) mutation associated with laminopathy: A rare cause of idiopathic acro-osteolysis.
        Joint Bone Spine. 2019; 86: 525-527
        • Grelet M.
        • Blanck V.
        • Sigaudy S.
        • et al.
        Outcomes of 4 years of molecular genetic diagnosis on a panel of genes involved in premature aging syndromes, including laminopathies and related disorders.
        Orphanet J Rare Dis. 2019; 14: 288
        • Bollati M.
        • Barbiroli A.
        • Favalli V.
        • et al.
        Structures of the lamin A/C R335W and E347K mutants: Implications for dilated cardiolaminopathies.
        Biochem Bioph Res Co. 2012; 418: 217-221
        • Gangemi F.
        • Degano M.
        Disease-associated mutations in the coil 2B domain of human lamin A/C affect structural properties that mediate dimerization and intermediate filament formation.
        J Struct Biol. 2013; 181: 17-28
        • Strelkov S.V.
        • Schumacher J.
        • Burkhard P.
        • Aebi U.
        • Herrmann H.
        Crystal Structure of the Human Lamin A Coil 2B Dimer: Implications for the Head-to-tail Association of Nuclear Lamins.
        J Mol Biol. 2004; 343: 1067-1080
        • Cowan J.
        • Li D.
        • Gonzalez-Quintana J.
        • Morales A.
        • Hershberger R.E.
        Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.
        Circulation Cardiovascular genetics. 2010; 3: 6-14
        • Laurini E.
        • Martinelli V.
        • Lanzicher T.
        • et al.
        Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins.
        Cardiovasc Res. 2018; 114: 846-857
        • Pollex R.L.
        • Hegele R.A.
        Hutchinson–Gilford progeria syndrome.
        Clinical Genetics. 2004; 66: 375-381
        • Verstraeten V.L.R.M.
        • Caputo S.
        • MAMv Steensel
        • et al.
        The R439C mutation in LMNAcauses lamin oligomerization and susceptibility to oxidative stress.
        J Cell Mol Med. 2009; 13: 959-971
        • Desgrouas C.
        • Varlet A.-A.
        • Dutour A.
        • et al.
        Unraveling LMNA Mutations in Metabolic Syndrome: Cellular Phenotype and Clinical Pitfalls.
        Cells. 2020; 9: 310
        • Xiong L.
        • Zhao K.
        • Cao Y.
        • et al.
        Linking skeletal muscle aging with osteoporosis by lamin A/C deficiency.
        PLoS Biol. 2020; 18e3000731
        • Richards S.A.
        • Muter J.
        • Ritchie P.
        • Lattanzi G.
        • Hutchison C.J.
        The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine.
        Human Molecular Genetics. 2011; 20: 3997-4004
        • Maynard S.
        • Keijzers G.
        • Akbari M.
        • et al.
        Lamin A/C promotes DNA base excision repair.
        Nucleic Acids Res. 2019; 47: 11709-11728
        • Masi Ad
        • D'Apice M.R.
        • Ricordye R.
        • Tanzarella C.
        • Novelli G.
        The R527H mutation in LMNA gene causes an increased sensitivity to ionizing radiation.
        Cell Cycle. 2008; 7: 2030-2037
        • Orr N.
        • Arnaout R.
        • Gula L.J.
        • et al.
        A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation.
        Nat Commun. 2016; 7: 11303
        • Yamada N.
        • Asano Y.
        • Fujita M.
        • et al.
        Mutant KCNJ3 and KCNJ5 Potassium Channels as Novel Molecular Targets in Bradyarrhythmias and Atrial Fibrillation.
        Circulation. 2019; 139: 2157-2169
        • Nakajima K.
        • Aiba T.
        • Makiyama T.
        • et al.
        Clinical Manifestations and Long-Term Mortality in Lamin A/C Mutation Carriers From a Japanese Multicenter Registry.
        Circ J. 2018; 82: 2707-2714
        • Bisbal F.
        • Baranchuk A.
        • Braunwald E.
        • Bayes de Luna A.
        • Bayes-Genis A.
        Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.
        J Am Coll Cardiol. 2020; 75: 222-232